Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma.

Abstract:

BACKGROUND:Little is known about the natural growth characteristics of untreated glioblastoma before surgical or therapeutic intervention, because patients are rapidly treated after preliminary radiographic diagnosis. Understanding the growth characteristics of uninhibited human glioblastoma may be useful for characterizing changes in response to therapy. Thus, the objective of the current study was to explore tumor growth dynamics in a cohort of patients with untreated glioblastoma before surgical or therapeutic intervention. METHODS:Ninety-five patients with glioblastoma who had measurable enhancing disease on >2 magnetic resonance imaging scans before surgery were identified. Tumor growth rates were quantified in 4 different ways (the percentage change per day, the absolute rate of change per day, the estimated volumetric doubling time, and the radial expansion rate) using 3 different approaches (bidirectional product, enhancing disease, and total lesion volume). RESULTS:The median volumetric doubling time was 21.1 days, the percentage change in tumor volume was 2.1% per day, and the rate of change in total lesion volume was 0.18 cc per day. The length of follow-up between magnetic resonance imaging examinations should be >28 days to detect progressive disease with high specificity. Small initial tumor sizes (<3 cm in greatest dimension) are biased toward a large percentage change at follow-up. CONCLUSIONS:Presurgical, treatment-naive glioblastoma growth dynamics can be estimated in a variety of ways with similar results. The percentage changes in tumor size and volume depend on baseline tumor size and the time interval between scans. Cancer 2016;122:1718-27. © 2016 American Cancer Society.

journal_name

Cancer

journal_title

Cancer

authors

Ellingson BM,Nguyen HN,Lai A,Nechifor RE,Zaw O,Pope WB,Yong WH,Nghiemphu PL,Liau LM,Cloughesy TF

doi

10.1002/cncr.29957

subject

Has Abstract

pub_date

2016-06-01 00:00:00

pages

1718-27

issue

11

eissn

0008-543X

issn

1097-0142

journal_volume

122

pub_type

杂志文章

相关文献

CANCER文献大全
  • Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

    abstract::A prospective study of patients receiving cis-diaminedichloroplatin II (DDP) was carried out to determine if risk factors could be identified related to the patient's living habits or past medical history that would predict in which patients DDP neuropathy might develop. Sixty-nine patients receiving six different com...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880601)61:11<2192::aid-cncr282

    authors: Mollman JE,Glover DJ,Hogan WM,Furman RE

    更新日期:1988-06-01 00:00:00

  • Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.

    abstract:BACKGROUND:Cyclooxygenase 2 (COX-2)-dependent signaling represents a potential mechanism of resistance to therapy with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. This is mediated in part through an EGFR-independent activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regul...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.29480

    authors: Reckamp KL,Koczywas M,Cristea MC,Dowell JE,Wang HJ,Gardner BK,Milne GL,Figlin RA,Fishbein MC,Elashoff RM,Dubinett SM

    更新日期:2015-09-15 00:00:00

  • Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody.

    abstract:BACKGROUND:Bone morphogenetic proteins (BMP) induce ectopic bone formation in vivo and may play a role in normal bone development. In addition, bone morphogenetic activity, as measured in a bone-forming assay in immunodeficient, athymic nu/nu mice, is present in a proportion of osteosarcomas; this activity, which may b...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940101)73:1<85::aid-cncr282073

    authors: Yoshikawa H,Rettig WJ,Takaoka K,Alderman E,Rup B,Rosen V,Wozney JM,Lane JM,Huvos AG,Garin-Chesa P

    更新日期:1994-01-01 00:00:00

  • HBAg-positive chronic liver disease associated with cirrhosis and hepatocellular carcinoma in the Senoi.

    abstract::Necropsy and clinical data show that primary hepatocellular carcinoma (PHC) is the commonest cancer among the Senoi (a Malaysian aboringine group). The other aboringine tribes do not appear to have this high predilection for liver cancer. In the necropsy series, PHS was present in 10 out of 22 Senoi patients with cirr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197710)40:4<1618::aid-cncr282040

    authors: Sumithran E,Prathap K

    更新日期:1977-10-01 00:00:00

  • A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.

    abstract::A novel sequential administration schedule of PALA (N-phosphonoacetyl-L-aspartate) and thymidine to enhance the cytotoxic effect of 5-fluorouracil (5FU) was tested in 36 patients with advanced gastric cancer and 21 patients with advanced poorly differentiated (anaplastic) colorectal cancer. The potency of 5FU was dram...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19900901)66:5<853::aid-cncr28206

    authors: Windschitl HE,O'Connell MJ,Wieand HS,Krook JE,Rubin J,Moertel CG,Kugler JW,Pfeifle DM,Goldberg RM,Laurie JA

    更新日期:1990-09-01 00:00:00

  • A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.

    abstract:BACKGROUND:Topotecan (9-dimethylaminomethyl-10-hydroxycampthothecin) is a new topoisomerase I inhibitor with promising efficacy in the treatment of patients with small cell lung carcinoma (SCLC). Combination with a topoisomerase II inhibitor may potentate the therapeutic effect of topotecan, although there has been con...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.10836

    authors: Mok TS,Wong H,Zee B,Yu KH,Leung TW,Lee TW,Yim A,Chan AT,Yeo W,Chak K,Johnson P

    更新日期:2002-10-01 00:00:00

  • Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma.

    abstract::Eleven patients with advanced soft tissue sarcoma were treated with whole body hyperthermia (41.8 degrees C-43.0 degrees C) for 2 hours, doxorubicin (45 mg/m2) at the beginning of peak temperature and cyclophosphamide (1000 mg/m2) 6 hours after doxorubicin. Warming was accomplished with a nylon and vinyl mesh water pe...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840615)53:12<2585::aid-cncr282

    authors: Gerad H,van Echo DA,Whitacre M,Ashman M,Helrich M,Foy J,Ostrow S,Wiernik PH,Aisner J

    更新日期:1984-06-15 00:00:00

  • Ductal carcinoma in situ of the male breast.

    abstract:BACKGROUND:Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and treatment of this disea...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940815)74:4<1289::aid-cncr2820

    authors: Camus MG,Joshi MG,Mackarem G,Lee AK,Rossi RL,Munson JL,Buyske J,Barbarisi LJ,Sanders LE,Hughes KS

    更新日期:1994-08-15 00:00:00

  • An assessment of World Health Organization criteria for severe acute respiratory syndrome in patients with cancer.

    abstract:BACKGROUND:The differential diagnosis of severe acute respiratory syndrome (SARS) in patients with cancer can be challenging. Although diagnostic criteria for SARS have been issued by the World Health Organization (WHO), simple adoption of the established criteria may lead to overdiagnosis in patients with cancer or to...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20141

    authors: Gu J,Wu A,Li J,Zhang X,Fang J,Li M,Yao Y,Ke Y,Gu J,Chen M,You W

    更新日期:2004-04-01 00:00:00

  • Role of stromal-derived cytokines and growth factors in bone metastasis.

    abstract:BACKGROUND:Interactions between bone marrow-derived cytokines, growth factors, and tumors play a critical role in both the homing of tumors to the bone and the development of bone metastasis. Bone is a storehouse of latent growth factors produced by stromal cells and osteoblasts that, when activated during osteoclastic...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.11148

    authors: David Roodman G

    更新日期:2003-02-01 00:00:00

  • Radiotherapy in nonlentiginous melanoma of the head and neck.

    abstract::Thirty-seven patients with superficial spreading or nodular melanoma of the head and neck treated with irradiation are reviewed. Twenty-one patients were referred within three months of surgery. Six had an incisional biopsy followed by postoperative irradiation, 4 were locally controlled (1 dying of metastatic melanom...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811215)48:12<2599::aid-cncr282

    authors: Harwood AR,Dancuart F,Fitzpatrick PJ,Brown T

    更新日期:1981-12-15 00:00:00

  • Prostatic acid phosphatase in strumal carcinoids of the ovary. An immunohistochemical study.

    abstract:BACKGROUND:Strumal carcinoids (SC) are ovarian tumors containing thyroid parenchyma admixed with carcinoid elements. Microscopically, the carcinoid component of SC usually presents a ribbon or trabecular pattern similar to the pattern exhibited by hindgut carcinoids. The authors designed an immunohistochemical study to...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930901)72:5<1673::aid-cncr2820

    authors: Sidhu J,Sánchez RL

    更新日期:1993-09-01 00:00:00

  • Quantitative survival impact of composite treatment delays in head and neck cancer.

    abstract:BACKGROUND:Multidisciplinary management of head and neck cancer (HNC) must reconcile increasingly sophisticated subspecialty care with timeliness of care. Prior studies examined the individual effects of delays in diagnosis-to-treatment interval, postoperative interval, and radiation interval but did not consider them ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31533

    authors: Ho AS,Kim S,Tighiouart M,Mita A,Scher KS,Epstein JB,Laury A,Prasad R,Ali N,Patio C,Clair JM,Zumsteg ZS

    更新日期:2018-08-01 00:00:00

  • Unexpectedly frequent hepatitis B reactivation by chemoradiation in postgastrectomy patients.

    abstract:BACKGROUND:Postgastrectomy patients undergoing chemoradiation risk chemoradiation-induced liver disease (CRILD). The objectives of this study were to investigate dosimetric implications and assess biologic susceptibility to CRILD in these patients. METHODS:Sixty-two patients with Stage IB-IV gastric/gastroesophageal a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20591

    authors: Cheng JC,Liu MC,Tsai SY,Fang WT,Jer-Min Jian J,Sung JL

    更新日期:2004-11-01 00:00:00

  • Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C): prolongation of disease-free interval and survival.

    abstract::The poor postsurgical prognosis in patients with colorectal cancer of the Dukes' C classification has prompted a clinical trial of adjuvant immunotherapy versus chemoimmunotherapy intended to prolong either the disease-free interval or the overall survival or both. One hundred and twenty-one patients have been entered...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197711)40:5+<2726::aid-cncr28204

    authors: Mavligit GM,Gutterman JU,Malahy MA,Burgess MA,McBride CM,Jubert A,Hersh EM

    更新日期:1977-11-01 00:00:00

  • Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon.

    abstract::Two-hundred-four patients with previously untreated adenocarcinoma of rectum, rectosigmoid, and sigmoid colon were retrospectively evaluated to determine patterns of recurrence following curative resection. Seventy-eight (38%) subsequently developed recurrent disease. Of these, 40% (31/78) presented with local recurre...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810915)48:6<1492::aid-cncr2820

    authors: Rao AR,Kagan AR,Chan PM,Gilbert HA,Nussbaum H,Hintz BL

    更新日期:1981-09-15 00:00:00

  • The value of ultrasonic imaging and CT scanning in planning the radiotherapy for prostatic carcinoma.

    abstract::Forty-four consecutive patients with potentially curable carcinoma of the prostate were localized with an Old Delft Simulator with the methods described by Bagshaw. The isocenter and the treatment portal were marked on the skin of the patient. Subsequently, the adequacy of the portal was checked by ultrasonography and...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800215)45:4<724::aid-cncr28204

    authors: Lee DJ,Leibel S,Shiels R,Sanders R,Siegelman S,Order S

    更新日期:1980-02-15 00:00:00

  • A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.

    abstract:BACKGROUND:Circulating immune complexes (CIC) have been implicated as a cause of malignancy-associated immunosuppression and disease progression. Previous attempts to remove CIC by pheresis or immunoadsorption over a Staphylococcus aureus protein A column have resulted in a few clinical responses, however the relations...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19950415)75:8<2099::aid-cncr2820

    authors: Fennelly DW,Norton L,Sznol M,Hakes TB

    更新日期:1995-04-15 00:00:00

  • Giant cell tumor ("osteoclastoma") of the pancreas: a tumor of epithelial origin.

    abstract::Carcinomas of the pancreas with giant cells are not rare, but those containing osteoclast-like tumor cells are quite unusual. This report documents a pancreatic neoplasm comprising both easily recognizable well-differentiated adenocarcinoma and osteoclast-like tumor. The literature on the "osteoclastoma" of the pancre...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811101)48:9<2022::aid-cncr2820

    authors: Trepeta RW,Mathur B,Lagin S,LiVolsi VA

    更新日期:1981-11-01 00:00:00

  • Primary hepatic or hepatosplenic non-Hodgkin's lymphoma in children.

    abstract::Non-Hodgkin's lymphoma confined to the liver is unusual in adults and has not been reported in children. Two children with primary hepatic and one with hepatosplenic NHL are described. All three patients are males, and both tumors examined for cell surface markers were of B-cell origin. Two patients, treated with chem...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19831215)52:12<2285::aid-cncr282

    authors: Miller ST,Wollner N,Meyers PA,Exelby P,Jereb B,Miller DR

    更新日期:1983-12-15 00:00:00

  • Hiccups with high dose dexamethasone administration: a case report.

    abstract:BACKGROUND:A 59-year-old male developed intractable hiccups during monthly therapy with high dose dexamethasone for multiple myeloma. Hiccups would begin hours after his first dose and continue over the 4 days of therapy. He sought assistance after his attempt at home remedies failed and the hiccups became exhausting. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19980115)82:2<415::aid-cnc

    authors: Cersosimo RJ,Brophy MT

    更新日期:1998-01-15 00:00:00

  • Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.

    abstract:BACKGROUND:Early-phase trials in patients with recurrent neuroblastoma historically used an objective "response" of measureable disease (Response Evaluation Criteria In Solid Tumors [RECIST], without bone/bone marrow assessment) to select agents for further study. Historical cohorts may be small and potentially biased;...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1002/cncr.30934

    authors: London WB,Bagatell R,Weigel BJ,Fox E,Guo D,Van Ryn C,Naranjo A,Park JR

    更新日期:2017-12-15 00:00:00

  • No evidence of overweight in long-term survivors of childhood cancer after glucocorticoid treatment.

    abstract:BACKGROUND:Glucocorticoids can lead to weight gain during cancer treatment, but to the authors' knowledge, little is known regarding their long-term effects in childhood cancer survivors (CCS). METHODS:As part of the Swiss Childhood Cancer Survivor Study, the authors sent a questionnaire to CCS aged <21 years at diagn...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31599

    authors: Belle FN,Kasteler R,Schindera C,Bochud M,Ammann RA,von der Weid NX,Kuehni CE,Swiss Pediatric Oncology Group (SPOG).

    更新日期:2018-09-01 00:00:00

  • End-of-life care in Medicare beneficiaries dying with pancreatic cancer.

    abstract:BACKGROUND:The authors' goal was to characterize hospice enrollment and aggressiveness of care for pancreatic cancer patients at the end of life. METHODS:Surveillance, Epidemiology, and End Results and linked Medicare claims data (1992-2006) were used to identify patients with pancreatic cancer who had died (n = 22,81...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26115

    authors: Sheffield KM,Boyd CA,Benarroch-Gampel J,Kuo YF,Cooksley CD,Riall TS

    更新日期:2011-11-01 00:00:00

  • Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma.

    abstract:BACKGROUND:The authors report the long-term treatment results for advanced stage base of tongue (BOT) and tonsillar fossa (TF) carcinomas treated with surgery and postoperative radiation therapy (RT) at Memorial Sloan-Kettering Cancer Center. METHODS:Between 1973 and 1986, 51 patients with squamous cell carcinoma of t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19921115)70:10<2388::aid-cncr282

    authors: Zelefsky MJ,Harrison LB,Armstrong JG

    更新日期:1992-11-15 00:00:00

  • Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen: long-term follow-up results.

    abstract:BACKGROUND:Patients with aggressive non-Hodgkin lymphoma (NHL) require intensive and extensive therapy, which seems impracticable in elderly patients due to hematologic and extrahematologic toxicity. Consequent dose reduction and therapy attenuation can reduce treatment-related toxicity but also decreases therapeutic e...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.11032

    authors: Rigacci L,Carpaneto A,Alterini R,Carrai V,Bernardi F,Bellesi G,Longo G,Bosi A,Rossi Ferrini P

    更新日期:2003-01-01 00:00:00

  • Primary non-Hodgkin's lymphoma of the mediastinum.

    abstract::Non-Hodgkin's lymphoma localized to the mediastinum and adjacent structures occurred in 12 of 215 (6+) non-Hodgkin's lymphoma patients seen at the Massachusetts General Hospital between 1975 and 1979. Lymphangiography, radionuclide scanning and whole body computerized tomography were used to exclude patients with extr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19821201)50:11<2486::aid-cncr282

    authors: Levitt LJ,Aisenberg AC,Harris NL,Linggood RM,Poppema S

    更新日期:1982-12-01 00:00:00

  • A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.

    abstract:BACKGROUND:Anemia in patients receiving chemotherapy can be ameliorated with recombinant human erythropoietin (rHuEPO), which is administered one to three times per week. Darbepoetin alpha, a new erythropoietic agent, has longer serum residence time, allowing it to be administered less frequently. METHODS:Patients (n ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/cncr.11186

    authors: Glaspy JA,Jadeja JS,Justice G,Fleishman A,Rossi G,Colowick AB

    更新日期:2003-03-01 00:00:00

  • High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.

    abstract:BACKGROUND:Many patients with hepatocellular carcinoma are positive for hepatitis B surface antigen (HBsAg) or antibodies to hepatitis C virus (anti-HCV). Recently, transfusion-transmitted virus (TTV) DNA was identified in the serum of patients with non-B, non-C posttransfusion hepatitis. In this study, the prevalence ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Nakagawa N,Ikoma J,Ishihara T,Yasui N,Fujita N,Iwasa M,Kaito M,Watanabe S,Adachi Y

    更新日期:1999-10-15 00:00:00

  • Chemotherapy of large intestinal carcinoma. Current results and future prospects.

    abstract::Chemotherapy of advanced stages of large bowel cancer has until recently made little progress since the introduction of 5-FU 16 years ago. While survival is improved for patients who respond, 5-FU alone has made little impact on life span of the overall population of patients. Mitomycin-C and the chloroethyl nitrosour...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(197512)36:6<2418::aid-cncr282036

    authors: Schein PS,Kisner D,MacDonald JS

    更新日期:1975-12-01 00:00:00